Form 8-K - Current report:
SEC Accession No. 0000950170-25-058705
Filing Date
2025-04-25
Accepted
2025-04-25 16:06:24
Documents
11
Period of Report
2025-04-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K ivvd-20250421.htm   iXBRL 8-K 59664
  Complete submission text file 0000950170-25-058705.txt   180496

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20250421.xsd EX-101.SCH 27556
13 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20250421_htm.xml XML 4874
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 25873935
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)